Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease

NeuroReport

Volumn 7, Issue 13, 1996, Pages 2155-2158

  Kehoe, Patrick ^a   Williams, Julie ^a   Holmans, Peter ^a   Liddell, Malcolm ^a   Lovestone, Simon ^b   Holmes, Clive ^b   Powell, John ^b   Neal, J ^a   Wilcock, Gordon ^c   Owen, Michael J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Alzheimer's disease; Apolipoprotein E; Polymorphism; Presenilin 1; Risk factors

Indexed keywords

APOLIPOPROTEIN E; PRESENILIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 10244234211     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199609020-00019     Document Type: Article

References (14)

1. McGuffin P, Owen MJ, O'Donovan MC et al. Seminars in Psychiatric Genetics. London: Gaskell Press, 1994.
2. Goate A, Chartier-Harlin MC, Mullan M et al. Nature 349, 704-706 (1991).
3. Broeckhoven C. Nature Genet 11, 230-232 (1995).
4. Sherrington R, Rogaev EI, Lian Y et al. Nature 375, 754-760 (1995).
5. Levy-Lahad E, Wijsman EM, Nemens E et al. Science 269, 970-973 (1995).
6. Levy-Lehad E, Wasco W, Poorkaj P et al. Science 269, 973-977 (1995).
7. Wragg M. Mutton M, Talbot C et al. Lancet 347, 509-512 (1995).
8. Rogaev EI, Sherrington R, Rogaeva G et al. Nature 376, 775-778 (1995).
9. Wisniewski T, Lalowski M, Golabek A et al. Lancet 345, 956-958 (1995).
10. McKhann G, Drachman D, Folstein M et al. Neurology 34, 939-944 (1984).
11. Folstein MF, Folstein SE and McHugh PR. J Psych Res 12, 189-98 (1975).
12. Holmes C, Copper B and Levy R. Int J Geriat Psych 10, 875-881 (1995).
13. Braak H and Braak E. Acta Neuropathol 82, 239-259 (1991).
14. Wenham PR, Price WH and Blundell G. Lancet 337, 1158-1159 (1991).